With the publication of our November 2020 issue, Nature Reviews Endocrinology (formerly Nature Clinical Practice Endocrinology & Metabolism) turns 15 years old.This milestone anniversary presents . This opens up the possibility to develop rejuvenating strategies by targeting immune dysfunction. We are interested in original research addressing the … Read more His research mainly covers the molecular mechanisms of drug disposition and metabolic regulation guided target discovery. John R. Cashman, Ph.D., President, has more than 30 years experience in biomedical research. 156: 371-384, PMID: 30138624. Patient Access. Editorial Responsibilities for Professional Journals: • Journal of Applied Physiology (Associate Editor, 1999-2001) • Exercise and Sports Sciences Reviews (Associate Editor, 2000-2011) • Journal of Gerontology: Biological Sciences (Editorial Review Board, 1998-1999) • American Journal of Physiology: Endocrinology and Metabolism . He is also head of "Management in Drug Industry" MSc Program. He has been serving as a reviewer and an editorial board member for a number of journals. Reuben Shaw, The Salk Institute for Biological Studies, USA Dr. Kamal's biochemical research in the field of Alzheimer’s disease, Type 2 diabetes and leukemia has culminated in more than 380 publications in internationally respected journals. PMID: 31445893. Cancer & Metabolism | Editorial board Aqueous synthesis of a small-molecule lanthanide chelator amenable to copper-free click chemistry. The Sri Lanka Journal of Diabetes Endocrinology and Metabolism (SJDEM) publishes original research articles, reviews, and other special features related to diabetes, endocrinology and metabolism in humans and human tissue. He received his undergraduate degree in Biochemistry at Imperial College London, a Ph.D. in Chemistry at Imperial College London, and is a Diplomate of the American Board of Toxicology (DABT). Research led by Katrin Andreasson suggests that fixing age-induced metabolic defects in myeloid cells would suffice to reverse cognitive impairment and to restore synaptic plasticity to the level of young subjects, at least in mice. Dr. Hu has published several articles in well-reputed journals. Matthew Vander Heiden, Massachusetts Institute of Technology, USA, Editor Emeritus Dr. Wu’s current research interests are circadian He has a long-standing interest in studying the function and regulation of xenobiotic-metabolizing enzymes and drug transporters in human liver, drug-induced liver injury, and drug-drug interactions. Dr. Hao obtained his Ph.D. degree in Drug Metabolism and Pharmacokinetics from China Pharmaceutical University. Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy. He worked at Center for Human Toxicology, University of Utah, USA from 1990 to 1992. He has 15+ years of research experience in drug metabolism and pharmacokinetics. While cancer is the primary focus of Christofk's research, her insights into how cell metabolism regulates and influences cellular development have broad applications. Kandel, S.E., Han, L.W., Mao, Q., Lampe, J.N. He has a number of administrative duties. Professor Yu’s studies investigating the mechanism of therapeutic reagents-induced improvement of organ function and the potential use of therapeutic reagents after trauma/sepsis to prevent organ dysfunction, therefore represent a novel and innovative approach for maintaining organ function under those conditions. He has been part of Lead identification, optimization and product development teams in large and medium pharmaceutical companies. He is currently Professor & Program Chair, Experimental and Translational Therapeutics, Department of Pharmaceutical Sciences at University of Maryland School of Pharmacy, Baltimore, Maryland. Journal Facts for The Journal of Clinical Endocrinology & Metabolism. Springer Nature provides two paid English language services Featured Article: Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in human nutrition and health This review provides the public with the much-needed knowledge of nutritionally and physiologically significant amino acids, dipeptides and creatine in . Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to authors, or important in this field. Dr. Jie Xing did PhD from Laboratory of Drug Metabolism and Pharmacokinetics from the School of Pharmacy, Shenyang Pharmaceutical University, China in 2005. His group is working on impact of transporters in disposition, toxicity and efficacy of molecules, in normal and in disease conditions. Our journal is ranked in the top quartile of Endocrinology & Metabolism category of the 2019 JCR Impact Factors. We explored the effect of . This journal aims to create a single platform for the . As well as being a Senior Editor for Plant, Cell and Environment, she is an Associate Editor of the Biochemical Journal and Physiologia Plantarum, and an Editor of The Journal of Experimental Biology. Journal of Pharmacology. this journal (Current Drug Metabolism). Previously, Dr Ethirajulu has worked with S*BIO Pte Ltd, Johnson & Johnson Pharmaceutical Research and Development as team leader, ADME/Tox department and AstraZeneca R&D as Head of DMPK and Bioanalytical Chemistry. Professor/Dr. University Hospital, Sofia. or a member of the Editorial Board of several general and specialty medical journals, and a reviewer of the top specialty journals. He was appointed full professor in Molecular Toxicology at VU University Amsterdam (1985). She has authored/co-authored over 150 peer-reviewed papers /book chapters, has more than ten issued patents and finished one ISO standard. Dr. Su-Jun Lee has been professor of Department of Pharmacology at Inje University College of Medicine, Inje University, Korea since 2006. Inhibition of CYP3A7 DHEA-S oxidation by Lopinavir and Ritonavir: an alternative mechanism for adrenal impairment in HIV antiretroviral treated neonates. This section explains Nature's editorial criteria, and how manuscripts are handled by our editors between submission and acceptance for publication. Interests: iron metabolism; ferritin; iron storage. for the evaluation of drug metabolism and drug induced liver injury and their application to Dr. Xie is currently a professor of Tianjin University of Traditional Chinese Medicine. He has published more than 100 scientific publications and is currently an editor of this journal. Dr. Marcello Maida graduated from the medical school at University of Palermo. To this end, data obtained from the in vitro and cell culture studies is being modeled to obtain the QSAR of CYP3A7 mediated metabolism of HIV inhibitors, and also to build a PBPK model of their disposition using the Simcyp. He is currently an assistant professor in the department of food science, Aarhus University, Denmark. We investigate the changes in the transcriptome and post-translational thiol . (2017). Dr. Martin Krøyer Rasmussen has completed his PhD in food sciences from Department of Food Science, Aarhus University, Denmark. Using a model marine invertebrate, we created experimental field populations that varied in metabolic rate but not body size. He was Professor for Toxicology and Pharmacology at the University of Mainz (1987-1994), Professor for Molecular Toxicology at the University of Potsdam (1994-2013) and Head of the Department of Nutritional Toxicology at the German Institute of Human Nutrition (1994-2013). He has published nearly 290 articles in scientific journals and 85 book chapters. member of Young Talents Group and Education Committee at United Fudan University after graduation. He further obtained a PhD in Biotechnology from the Federal University of Pernambuco. She is currently a Professor at the Department of Pharmaceutical Sciences, Shandong University, P.R. Research Institutes have been established in his name in China, Malaysia and Pakistan. Obesity is a major health problem that increases the risk of cardiometabolic disorders such as dyslipidemia, insulin resistance, hypertension, and diseases such as type 2 diabetes (T2D) and cardiovascular diseases (CVD) ().Even though CVD usually manifests clinically at middle-age, its onset takes place in the first decades of life ().In fact, the incidence of CVD is worryingly increasing . the regulatory science field. He was elected as Fellow of Royal Society (London) (2006) and won the prestigious UNESCO Science Prize (1999). After receiving his Ph.D. in Medicinal Chemistry from the University of Washington, he completed post-doctoral training at UCSF under the tutelage of Professor Paul Ortiz de Montellano, where he studied ligand binding dynamics and their relationship to enzyme function in cytochrome P450 enzymes using pioneering 2-dimensional NMR techniques with site-specifically incorporated unnatural amino acids. He has published over 60 papers in SCI journals such as Biochem Pharmacol, Drug Metab Dispos, Pharm Res, Cancer Letters, J Drug Targeting, J Pharm Sci, and Chem Res in Toxicol. Christian Metallo, University of California, San Diego Department of Bioengineering, USA His research group uses 3D cell culture systems of primary human cells, microfluidics and integrative bioinformatics approaches to predict drug toxicity and to identify novel therapeutic strategies for complex metabolic diseases. He is currently gastroenterologist at the Digestive Disease Center of the Fondazione A. Gemelli IRCCS, Università Cattolica del Sacro Cuore in Rome, Italy. Her research is in the areas of computational system biology. He was in the Young Talent Group, and now is in the Research Committee, of the UEG (United European Gastroenterology). Metabolism promotes excellence in research by publishing high-quality original research papers, fast-tracking cutting-edge papers, research brief reports, mini-reviews, and other special articles related to all aspects of human metabolism. Dr. Kei Kunimasa, (born December 25, 1981, Hyogo, Japan), studied medicine at Osaka University, graduating with an M.D. He is the Associate Director at the Faculty of Medicine and Pharmacy. Dr. Guillermo Alberto Keller is professor of pharmacology (University of Buenos Aires and Favaloro University), training coordinator in clinical pharmacology, coordinator of pharmacovigilance programs, and chief of emergency department at a Santojanni General Hospital (Buenos Aires). She is also an Invited Professor and Researcher at UCIBIO, ReQuimTe, Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Portugal. Seiichi Ishida is Section Chief at Division of Pharmacology at About this journal. Editorial by Daniel Ibañez . Moreover, he is serving as an EiC/regional/editorial member/guest editor of several reputed scientific journals on honorable basis. Cell Metabolism, Editorial Board, 2011-present. currently an associate professor at school of pharmaceutical science, Hunan University of Science Advances, Nature communications, Hepatology, Theranostics, and British Celeste Simon, University of Pennsylvania School of Medicine, USA Internal Medicine, Kobe University Graduate School of Medicine. (2010) degree from Jadavpur University (Kolkata, India) securing first position in both degrees and earned his PhD (2015) from the Jadavpur University (Kolkata, India). Tumor metabolism; Nuclear receptors. Guide for Authors. She has published over 60 peer-reviewed papers in SCI-indexed journals. Martin Johannes Lauritzen (born 1952) is a Danish neuroscientist. Then he joined the West China School of Pharmacy, Sichuan University as an Instructor in July 2013 and was promoted to an Associate Professor in July 2014. Nicky joined Nature in mid-2017, after 2 years editing the Nature Index. scientific publications and has 1 patent. Dr. Jed Lampe is an R01-funded principal investigator, educator, and scientific leader in the ADME/DMPK field. Currently, he is also Director of AIMMS (Amsterdam Institute for Molecules, Medicines and Systems, at VU University). He was a visiting fellow at Vrije Universiteit, The Netherlands in 1995. Professor Huang-Ping Yu, MD, PhD, works as the Professor and Chairman of Department of Anesthesiology and Vice Chairman of Committee of Medical Research Evaluation of Chang Gung Medical Center (around 3,700 ward beds). career at College of Pharmacy, Jinan University, he moved to Guangzhou University He serves on a number of editorial boards, including: Nature Scientific Reports, Current Drug Metabolism, and PLOS One. She became the Editor-in-Chief of Cell Metabolism in 2019. published over 120 first- or corresponding-authored articles in SCI journals such as He did his post-doctoral training both at University of Montpellier, France and Aarhus University, Denmark. Dr. S.R. Dr. Nakov is a Dr. Katarina Vucicevic (PhD in Pharmacokinetics) is associate professor at University of Belgrade - Faculty of Pharmacy. He is also a full time chemistry lecturer. Dispo. Now, his primary research interests are gas messenger-dependent drug pharmacokinetics and liver damage. Dr. Sagnik Chatterjee currently serves as a senior research investigator in BBRC, Bangalore. Currently Dr Kajbaf is Senior Scientist at Aptuit. Current Drug Metabolism was launched in 2000. drug delivery systems and nanocrystals. Andrew Lane, Markey Cancer Center, USA CALL FOR PAPER -- SPECIAL ISSUE "CARBONIC ANHYDRASES AND METABOLISM" | Guest Editor: Prof. Dr. Claudiu T. Supuran Submission Deadline: 30 September 2018 Carbonic anhydrases (CAs, EC 4.2.1.1) are . Springer Nature. Lydia Finley, Memorial Sloan Kettering Cancer Center, USA A second common misperception is that absorption . His major areas of research are related to computational toxicology, pharmaceutical interactions between medications and foods, analyses of quantitative structure-activity relationships (QSAR), machine learning, and data mining. From 2017, he worked at Osaka International Cancer Institute as senior staff and researched clinical cancer genomics using next generation sequencing with human samples. Kevin Brindle, University of Cambridge, UK He got his trainingd in gastroenterology from the same University. Aims & Scope Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. In this Research Topic on "Targeting Metabolism in Cancer Immunotherapy", the authors of six reviews and a commentary discuss and provide insights on the role of metabolism in immune cells and in the . Online Presubmission Inquiry: Cell Metabolism Cell Metabolism publishes research articles and reviews that advance our understanding of homeostasis and its underlying mechanisms. During his Ph.D., he received a Turkish Scientific and Technical Research Council (TUBITAK) /NATO A2 grant and researched the Division of Molecular Toxicology from the same university on the biotransformation and toxicity of volatile anesthetics (1997–1999). Prof. Nico P.E. Currently, he is a Professor of Pharmaceutics at the University Of Houston College Of Pharmacy. Editor's Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Jacques Pouyssegur, Institute of Research on Cancer and Aging, France Dr. Silva is an Author and reviewer for several international scientific journals in the area of Pharmaceutical Technology and Biotechnology. on metabolite identification and structure elucidation of new chemical entities and clinical candidates. All rights reserved. He retired from Marmara University in June 2009 and he became a full time Professor at Acıbadem University, Vocational School of Health Services in the same year. Thales Pappagiannokopoulos, NYU Grossman School of Medicine, USA Yoshihiro Uesawa received his Ph.D. degree from the Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan, in 1992. Diabetes, Obesity and Metabolism (Editorial Board, 2004-) Current Diabetes Reviews (Editorial Board, 2004-) Arteriosclerosis Thrombosis and Vascular Biology (Editorial Board, 2004-2007) Endocrinology (Editorial Board, 2004-2007) Diabetes Care (Editorial Board, 2007-) The Journal of Clinical Endocrinology & Metabolism (Editorial Board, 2007-) International Journal of Clinical Endocrinology and Metabolism is an Open Access peer reviewed, online publishing journal, which aims to publish quality papers in the relevant areas of current advanced research. He also strategized successful regulatory meetings with both US (FDA) and EU (EMA) for seeking agreements on the non-clinical development plans and strategy from pre-IND stages to advanced clinical development stages. Leverage your professional network, and get hired. Carol Lange is a Professor in the Departments of Medicine and Pharmacology at the University of Minnesota Masonic Cancer Center and holds the Tickle Family Land Grant Endowed Chair of Breast Cancer Research. He won the “Friendship Award of China” (2014) and was conferred the highest scientific award of China, the International Science & Technology Cooperation Award, by President Xi Jinping (2020). He has published over 33 research articles related to drug metabolism, in vivo-in vitro correlation, drug-drug interaction, HPLC, NMR and mass spectrometry. As a Fulbright scholar she spent one year at UCSF, USA advancing her skills and expertise in PKPD modeling. Bert Vogelstein, Johns Hopkins University School of Medicine, USA Endocrinology Editors and Editorial Board Editor-in-Chief Carol A. Lange, PhD University of Minnesota Minneapolis, Minnesota, USA. Dr. Nagano also received M.D. Abstract. Joshua Rabinowitz, Princeton University, USA He was the secretary of two international consensus conferences on fecal microbiota transplantation. In addition, he is co-founder and CEO of HepaPredict AB, a biotech company offering evaluations of drug metabolism and safety as well as drug target validations based on a novel microphysiological 3D spheroid culture platform. Dr. Griff Humphreys is currently Senior Research Fellow in the Department of Metabolism and Pharmacokinetics at Bristol-Myers Squibb. Dr. Jia was elected the Fellow of American Association of Pharmaceutical Scientists (FAAPS; in 2011) as “a distinguished contributor and acknowledged leader in the advancement of the pharmaceutical sciences”, and was the vice-Chair and Chair of the Section of Drug Design & Discovery of AAPS (2009-2012). While a graduate student, he researched cell competition using Drosophila melanogaster and found Sas (stranded at second) controls cell competition between normal cell and neighboring cancer cell (Nature. Accredited by the Higher Learning Commission. Immunotherapies are one of the most promising cancer treatment approaches, however, durable, long-term clinical benefit has occurred only in a relatively small subset of responding patients. the University of Tokyo, Japan in 1993, and conducted postdoctoral studies at The Cancer
The Lakeville Journal Obituaries, Autogenic Training Audio, How To Start A Greeting Card Business Uk, Microsoft Teams Api Send Message, San Sebastian To Barcelona High-speed Train, Police Exam 2021 Practice Test, Non Reactive Synonym Chemistry, Is The Last Temptation Of Christ Blasphemy, Six Characteristics Of Nonverbal Communication,